ACME Laboratories (DHA:ACMELAB) Net Change in Cash : BDT716 Mil (TTM As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is ACME Laboratories Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

ACME Laboratories's Net Change in Cash for the three months ended in Mar. 2024 was BDT0 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 was BDT716 Mil.

ACME Laboratories Net Change in Cash Historical Data

The historical data trend for ACME Laboratories's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ACME Laboratories Net Change in Cash Chart

ACME Laboratories Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Net Change in Cash

Get a 7-Day Free Trial

242.69

446.06

-229.97

-354.94

216.47

ACME Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Mar24
Net Change in Cash	Get a 7-Day Free Trial															696.49	-689.05	-71.12	779.55	-

ACME Laboratories Net Change in Cash Calculation

ACME Laboratories's Net Change in Cash for the fiscal year that ended in Jun. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	1258.883	+	-5238.704	+	4196.289	+	0
	=	216

ACME Laboratories's Net Change in Cash for the quarter that ended in Mar. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 0 + 0 + 0 + 0

= 0

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT716 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ACME Laboratories Net Change in Cash Related Terms
Thank you for viewing the detailed overview of ACME Laboratories's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

ACME Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ACME Laboratories Ltd (DHA:ACMELAB) » Definitions » Net Change in Cash

Comparable Companies

DHA:ORIONINFU DHA:AFCAGRO DHA:BEACONPHAR DHA:BXPHARMA ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692 NSE:DIVISLAB BOM:500124 VTRS NBIX SZSE:000963 SHSE:600085

Traded in Other Exchanges

N/A

Address

1/4, Kallayanpur, Mirpur Road, Court de la ACME, Dhaka, BGD, 1207

Website

https://www.acmeglobal.com

ACME Laboratories Ltd is engaged in the manufacturing, marketing, and distribution of generic pharmaceutical products in Bangladesh. The company offers pharmaceutical, ayurvedic, herbal, nutraceutical products, and veterinary products. It produces various forms of dosage including tablet, capsule, dry syrup, cream, ointment, powder and injection among others.

ACME Laboratories Headlines

No Headlines